The HYdrocortisone for Bronchopulmonary Dysplasia Respiratory and Developmental (HYBRiD) outcomes study: protocol for a longitudinal cohort study.

The HYdrocortisone for Bronchopulmonary Dysplasia Respiratory and Developmental (HYBRiD) outcomes study: protocol for a longitudinal cohort study. BMC Pediatr. 2024 Nov 14; 24(1):737.

View in: PubMed

subject areas

Bronchopulmonary Dysplasia
Child
Child Development
Child, Preschool
Clinical Trials, Phase III as Topic
Female
Follow-Up Studies
Humans
Hydrocortisone
Infant
Infant, Extremely Premature
Infant, Newborn
Longitudinal Studies
Male
Randomized Controlled Trials as Topic

authors with profiles

Michael Msall